|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's range||43.7740 - 44.9350|
|52-week range||43.7740 - 44.9350|
|Beta (5Y monthly)||2.41|
|PE ratio (TTM)||N/A|
|Earnings date||28 Feb 2022 - 04 Mar 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The big shareholder groups in Axsome Therapeutics, Inc. ( NASDAQ:AXSM ) have power over the company. Institutions often...
The first half of the year is over. And good riddance. The S&P 500 experienced its worst first half in more than 50 years. Most investors saw the values of their holdings plunge. But the stock market won't remain in the doldrums forever.
Here's why these Fool.com contributors are bullish on Adaptimmune Therapeutics, G1 Therapeutics, and Axsome Therapeutics.